Prime Medicine seeks FDA treatment approval after two-patient trial is drawing significant interest across the industry.
Prime Medicine's application will test an FDA that has promised to speed new gene-editing treatments but has recently spurned some.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →